Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation

Cannabis and psychosis: Neurobiology

(2014) Amresh Shrivastava et al.   Indian Journal of Psychiatry

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

(2013) Daniel J Hermanson et al.   NATURE NEUROSCIENCE

50 years of hurdles and hope in anxiolytic drug discovery

(2013) Guy Griebel et al.   NATURE REVIEWS DRUG DISCOVERY

Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks

(2013) Matthew N. Hill et al.   PSYCHONEUROENDOCRINOLOGY

Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice

(2013) Joyonna C. Gamble-George et al.   PSYCHOPHARMACOLOGY

Amygdala FAAH and anandamide: mediating protection and recovery from stress

(2013) Ozge Gunduz-Cinar et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Stress and anxiety across the lifespan: structural plasticity and epigenetic regulation

(2013) Richard G Hunter et al.   Epigenomics

Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure

(2012) M N Hill et al.   MOLECULAR PSYCHIATRY

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity

(2012) O Gunduz-Cinar et al.   MOLECULAR PSYCHIATRY

Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans

(2012) Andrea Dlugos et al.   NEUROPSYCHOPHARMACOLOGY

Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice

(2011) N.P. Bowles et al.   NEUROSCIENCE

Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats

(2011) Natale R. Sciolino et al.   PHARMACOLOGICAL RESEARCH

Fast Feedback Inhibition of the HPA Axis by Glucocorticoids Is Mediated by Endocannabinoid Signaling

(2010) Nathan K. Evanson et al.   ENDOCRINOLOGY

Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition

(2010) S. Rossi et al.   MOLECULAR PHARMACOLOGY

Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress

(2010) Wei Wang et al.   NEUROPSYCHOPHARMACOLOGY

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay

(2010) Steven G. Kinsey et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

(2009) Fabrício A. Moreira et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats

(2009) J. Haller et al.   PSYCHOPHARMACOLOGY

Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders

(2008) Boris B. Gorzalka et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report

(2008) M. Hill et al.   PHARMACOPSYCHIATRY

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

(2007) Fabricio A. Moreira et al.   NEUROPHARMACOLOGY

Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice

(2007) David J. Rademacher et al.   NEUROPHARMACOLOGY